Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meds Apotek AB (publ)FRA:24R +0.46%9 Debt-to-Equity is 0.02 as of Jun. 2026, which is 90% below its 10-year median of 0.20. GuruFocus rates FRA:24R with a GF Score™ of 9/100. The stock has 3 warning signs investors should review. Among 1,007 Retail - Cyclical companies, Meds Apotek AB (publ) ranks better than 96.92% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Meds Apotek AB (publ)'s Debt-to-Equity or its related term are showing as below:
FRA:24R'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.2 Max: 0.95
Current: 0.02
During the past 4 years, the highest Debt-to-Equity Ratio of Meds Apotek AB (publ) was 0.95. The lowest was 0.02. And the median was 0.20.
FRA:24R's Debt-to-Equity is ranked better than 96.92% of 1007
companies
in the Retail - Cyclical industry
Industry Median: 0.56
vs FRA:24R: 0.02
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Meds Apotek AB (publ) Debt-to-Equity Related Terms
Meds Apotek AB (publ) Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Meds Apotek AB (publ)'s Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:24R vs AMZN, BABA, PDD: Debt-to-Equity Comparison
For the Internet Retail subindustry, Meds Apotek AB (publ)'s Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) Debt-to-Equity vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) (FRA:24R) has a Debt-to-Equity of 0.02 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Meds Apotek AB (publ) and its competitors. This is 90% below median its historical median of 0.20. Over the past decade, Meds Apotek AB (publ)'s Debt-to-Equity has ranged from 0.02 to 0.95. According to the industry distribution chart, Meds Apotek AB (publ) ranks #31 out of 1007 companies in the Retail - Cyclical industry, placing it in the top 3.1%.
Is Meds Apotek AB (publ)'s Debt-to-Equity too high?
Meds Apotek AB (publ)'s current Debt-to-Equity of 0.02 is 90% below median its 10-year median of 0.20. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.95. The Retail - Cyclical industry median Debt-to-Equity is 0.56. Meds Apotek AB (publ)'s value of 0.02 is 96.4% below this industry median. Based on the distribution chart, Meds Apotek AB (publ) ranks #31 out of 1007 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Meds Apotek AB (publ) has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Debt-to-Equity compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, Meds Apotek AB (publ) ranks #31 out of 1007 companies for Debt-to-Equity. This places Meds Apotek AB (publ) in the top 3% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.56. Meds Apotek AB (publ)'s value of 0.02 is 96.4% below this benchmark. Historically, Meds Apotek AB (publ)'s own Debt-to-Equity has ranged from 0.02 to 0.95 over the past decade. While the company's 10-year median is 0.20 vs. the industry median of 0.56, Meds Apotek AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Retail - Cyclical company?
The median Debt-to-Equity among Retail - Cyclical companies is 0.56, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current Debt-to-Equity of 0.02 is 96.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Meds Apotek AB (publ) and its competitors. For the Retail - Cyclical industry, the median Debt-to-Equity is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current Debt-to-Equity is 0.02, which is 90% below median its own 10-year median of 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (FRA:24R) has a current Debt-to-Equity of 0.02. The current Debt-to-Equity is 0.02, which is 90% below median its 10-year median of 0.20 and 96.4% below the Retail - Cyclical industry median of 0.56. Meds Apotek AB (publ)'s overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Meds Apotek AB (publ) (FRA:24R), the current Debt-to-Equity is 0.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
9GF Score
Get the complete analysis for FRA:24R
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:24R has been successfully added to your 
